Autoantibodies in rheumatoid arthritis–laboratory and clinical perspectives

J Rönnelid, C Turesson, A Kastbom - Frontiers in immunology, 2021 - frontiersin.org
Measurement of two groups of autoantibodies, rheumatoid factor (RF) and anti-citrullinated
protein/peptide antibodies (ACPA) have gained increasing significance in the diagnosis and …

[HTML][HTML] Prediction of response to targeted treatment in rheumatoid arthritis

CA Wijbrandts, PP Tak - Mayo Clinic Proceedings, 2017 - Elsevier
Rheumatoid arthritis is an autoimmune syndrome presenting with chronic inflammation of
the joints. Patients with the same diagnosis can present with different phenotypes. In some …

Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs

S Enroth, Å Johansson, SB Enroth… - Nature …, 2014 - nature.com
Ideal biomarkers used for disease diagnosis should display deviating levels in affected
individuals only and be robust to factors unrelated to the disease. Here we show the impact …

The clinical value of autoantibodies in rheumatoid arthritis

S Bugatti, A Manzo, C Montecucco, R Caporali - Frontiers in medicine, 2018 - frontiersin.org
Rheumatoid arthritis (RA) is a highly heterogeneous syndrome in terms of clinical
presentation, progression, and response to therapy. In such a complicated context, the …

Toward overcoming treatment failure in rheumatoid arthritis

Z Wang, J Huang, D Xie, D He, A Lu… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is an autoimmune disorder characterized by inflammation and
bone erosion. The exact mechanism of RA is still unknown, but various immune cytokines …

The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus

R Giacomelli, A Afeltra, E Bartoloni, O Berardicurti… - Autoimmunity …, 2021 - Elsevier
Autoimmune diseases (AIDs) share similar serological, clinical, and radiological findings,
but, behind these common features, there are different pathogenic mechanisms, immune …

Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability

BVJ Cuppen, PMJ Welsing, JJ Sprengers… - …, 2016 - academic.oup.com
Objectives. To review studies that address prediction of response to biologic treatment in RA
and to explore the clinical utility of the studied (bio) markers. Methods. A search for relevant …

How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis

U Steffen, G Schett, A Bozec - Frontiers in immunology, 2019 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic inflammatory disease, characterized by autoimmunity
that triggers joint inflammation and tissue destruction. Traditional concepts of RA …

The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis

K Schinnerling, JC Aguillón, D Catalán… - Clinical & experimental …, 2017 - academic.oup.com
Therapeutic blockage of cytokine signalling in autoimmune diseases has improved our
understanding of the role of these cytokines in triggering, shaping and perpetuating …

[PDF][PDF] Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration

T Conrozier, A Lohse, JC Balblanc… - Clin Exp …, 2020 - clinexprheumatol.org
Objective Acute respiratory distress syndrome (ARDS) related to SARS-CoV-2 is likely due
to a cytokine storm characterised by a major release of pro-inflammatory cytokines, including …